Avidity Biosciences Inc (RNA)
26.33
-0.12
(-0.45%)
USD |
NASDAQ |
May 06, 16:00
26.48
+0.15
(+0.57%)
After-Hours: 07:28
Avidity Biosciences Cash and Short Term Investments (Quarterly): 595.35M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 595.35M |
| September 30, 2023 | 542.58M |
| June 30, 2023 | 576.50M |
| March 31, 2023 | 586.30M |
| December 31, 2022 | 610.73M |
| September 30, 2022 | 405.55M |
| June 30, 2022 | 398.22M |
| March 31, 2022 | 397.07M |
| December 31, 2021 | 405.54M |
| Date | Value |
|---|---|
| September 30, 2021 | 413.03M |
| June 30, 2021 | 279.46M |
| March 31, 2021 | 307.91M |
| December 31, 2020 | 328.14M |
| September 30, 2020 | 341.14M |
| June 30, 2020 | 352.45M |
| March 31, 2020 | 88.75M |
| December 31, 2019 | 94.58M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
88.75M
Minimum
Mar 2020
610.73M
Maximum
Dec 2022
395.49M
Average
398.22M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | 92.15M |
| Codexis Inc | 85.52M |
| Akoya Biosciences Inc | 83.12M |
| DocGo Inc | 59.29M |
| Kineta Inc | 5.783M |